EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pathogenic germline variants identified in pNEN patients during genetic testing

Tara Arouchian iD, Alexandra Gangi, Ka Wing Fung, Teodora Dumitra, Abrahm Levi, Arsen Osipov, Andrew E Hendifar

Endocrine Oncology · 01.01.2026 · 6 (1)

DOI: 10.1530/eo-25-0088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Oncology, online erschienen am 15.05.2026. Verfasst von Tara Arouchian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Samuel Oschin Comprehensive Cancer Center, Cedars Sinai Medical Center, Los Angeles, California, USA. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poor outcomes in pancreatic neuroendocrine neoplasms (pNENs) partially result from the inability to identify early-stage disease in patients. Prevention strategies have focused on identifying high-risk patients through genetic susceptibility genes. This study aims to report the incidence of pathogenic germline variants (PGVs) in pNEN. 129 pNEN patients that underwent germline testing with Invitae between September 5, 2019, and February 15, 2022, were retrospectively analyzed. PGVs were found in 14.7% (19/129) of pNENs. PGVs in pancreatitis genes were detected in 7.7% (3/39) of the 39 pNEN patients with an available pancreatitis panel. CFTR alterations were the most common pancreatitis-associated gene identified (5.1%, 2/39). MUTYH alterations were the most frequently detected (3.9%, 5/129) PGV in pNENs. DNA or base repair PGVs were found in 7.8% (10/129). Our findings suggest that germline testing may play a role in the standard-of-care management of pNEN. MUTYH alterations merit further evaluation as a potential risk factor for pNEN.

Schlagwörter

Stichwörter der Autor:innen

DNA repair genesgermline variantspancreatic neuroendocrine neoplasmsprecision medicine

Autor:innen und Institutionen

  • Samuel Oschin Comprehensive Cancer Center, Cedars Sinai Medical Center, Los Angeles, California, USA.
  • Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.

ORCID-Profile: Tara Arouchian

Zitieren

APA

Arouchian, T., Gangi, A., Fung, K. W., Dumitra, T., Levi, A., Osipov, A., & Hendifar, A. E. (2026). Pathogenic germline variants identified in pNEN patients during genetic testing. Endocrine Oncology, 6(1). https://doi.org/10.1530/eo-25-0088

Vancouver

Arouchian T, Gangi A, Fung KW, Dumitra T, Levi A, Osipov A, et al. Pathogenic germline variants identified in pNEN patients during genetic testing. Endocrine Oncology. 2026;6(1). doi:10.1530/eo-25-0088

BibTeX
@article{Arouchian2026,
  author = {Arouchian, Tara and Gangi, Alexandra and Fung, Ka Wing and Dumitra, Teodora and Levi, Abrahm and Osipov, Arsen and Hendifar, Andrew E},
  title = {Pathogenic germline variants identified in pNEN patients during genetic testing},
  journal = {Endocrine Oncology},
  year = {2026},
  volume = {6},
  number = {1},
  doi = {10.1530/eo-25-0088}
}
Kostenlos starten →